메뉴 건너뛰기




Volumn 29, Issue 7, 2015, Pages 1458-1469

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; TOLL LIKE RECEPTOR;

EID: 84937023314     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2015.69     Document Type: Review
Times cited : (190)

References (120)
  • 2
    • 84868201807 scopus 로고    scopus 로고
    • Molecular genetics in myelodysplastic syndromes
    • Haferlach T. Molecular genetics in myelodysplastic syndromes. Leuk Res. 2012; 36: 1459-1462
    • (2012) Leuk Res , vol.36 , pp. 1459-1462
    • Haferlach, T.1
  • 4
    • 84892967412 scopus 로고    scopus 로고
    • Inflammatory arthritis in patients with myelodysplastic syndromes: A multicenter retrospective study and literature review of 68 cases
    • Mekinian A, Braun T, Decaux O, Falgarone G, Toussirot E, Raffray L, et al. Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases. Medicine. 2014; 93: 1-10
    • (2014) Medicine , vol.93 , pp. 1-10
    • Mekinian, A.1    Braun, T.2    Decaux, O.3    Falgarone, G.4    Toussirot, E.5    Raffray, L.6
  • 5
    • 17344372458 scopus 로고    scopus 로고
    • Association between myelodysplastic syndromes and inflammatory bowel diseases report of seven new cases and review of the literature
    • Hebbar M, Kozlowski D, Wattel E, Mastrini S, Dievart M, Duclos B, et al. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia. 1997; 11: 2188-2191
    • (1997) Leukemia , vol.11 , pp. 2188-2191
    • Hebbar, M.1    Kozlowski, D.2    Wattel, E.3    Mastrini, S.4    Dievart, M.5    Duclos, B.6
  • 6
    • 44449119097 scopus 로고    scopus 로고
    • Concurrent inflammatory bowel disease and myelodysplastic syndrome: Report of nine new cases and a review of the literature
    • Wang Z, Zhou Y, Liu Y. Concurrent inflammatory bowel disease and myelodysplastic syndrome: report of nine new cases and a review of the literature. Digest Dis Sci. 2008; 53: 1929-1932
    • (2008) Digest Dis Sci , vol.53 , pp. 1929-1932
    • Wang, Z.1    Zhou, Y.2    Liu, Y.3
  • 7
    • 65449178870 scopus 로고    scopus 로고
    • Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells
    • Nakamura F, Watanabe T, Hori K, Ohara Y, Yamashita K, Tsuji Y, et al. Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells. Digestion. 2009; 79: 215-219
    • (2009) Digestion , vol.79 , pp. 215-219
    • Nakamura, F.1    Watanabe, T.2    Hori, K.3    Ohara, Y.4    Yamashita, K.5    Tsuji, Y.6
  • 8
    • 84879779773 scopus 로고    scopus 로고
    • Myelodysplastic syndromes and autoimmune diseases-case series and review of literature
    • Al Ustwani O, Ford LA, Sait SJ, Block AM, Barcos M, Vigil CE, et al. Myelodysplastic syndromes and autoimmune diseases-case series and review of literature. Leuk Res. 2013; 37: 894-899
    • (2013) Leuk Res , vol.37 , pp. 894-899
    • Al Ustwani, O.1    Ford, L.A.2    Sait, S.J.3    Block, A.M.4    Barcos, M.5    Vigil, C.E.6
  • 10
  • 12
    • 79952787641 scopus 로고    scopus 로고
    • Increased cancer risks among arthroplasty patients: 30 year follow-up of the swedish knee arthroplasty register
    • Wagner P, Olsson H, Lidgren L, Robertsson O, Ranstam J. Increased cancer risks among arthroplasty patients: 30 year follow-up of the Swedish Knee Arthroplasty Register. Eur J Cancer. 2011; 47: 1061-1071
    • (2011) Eur J Cancer , vol.47 , pp. 1061-1071
    • Wagner, P.1    Olsson, H.2    Lidgren, L.3    Robertsson, O.4    Ranstam, J.5
  • 13
    • 79960709287 scopus 로고    scopus 로고
    • Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes
    • Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 2011; 29: 2897-2903
    • (2011) J Clin Oncol , vol.29 , pp. 2897-2903
    • Kristinsson, S.Y.1    Bjorkholm, M.2    Hultcrantz, M.3    Derolf, A.R.4    Landgren, O.5    Goldin, L.R.6
  • 14
    • 0035865012 scopus 로고    scopus 로고
    • Cancer risk in patients with inflammatory bowel disease: A population-based study
    • Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001; 91: 854-862
    • (2001) Cancer , vol.91 , pp. 854-862
    • Bernstein, C.N.1    Blanchard, J.F.2    Kliewer, E.3    Wajda, A.4
  • 15
    • 17644386242 scopus 로고    scopus 로고
    • Risk of haematopoietic cancer in patients with inflammatory bowel disease
    • Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005; 54: 617-622
    • (2005) Gut , vol.54 , pp. 617-622
    • Askling, J.1    Brandt, L.2    Lapidus, A.3    Karlen, P.4    Bjorkholm, M.5    Lofberg, R.6
  • 17
    • 0030294026 scopus 로고    scopus 로고
    • Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes
    • Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, et al. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 1996; 20: 891-900
    • (1996) Leuk Res , vol.20 , pp. 891-900
    • Shetty, V.1    Mundle, S.2    Alvi, S.3    Showel, M.4    Broady-Robinson, L.5    Dar, S.6
  • 18
    • 0033389116 scopus 로고    scopus 로고
    • Measurement of MRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes
    • Allampallam K, Shetty V, Hussaini S, Mazzoran L, Zorat F, Huang R, et al. Measurement of MRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes. Anticancer Res. 1999; 19: 5323-5328
    • (1999) Anticancer Res , vol.19 , pp. 5323-5328
    • Allampallam, K.1    Shetty, V.2    Hussaini, S.3    Mazzoran, L.4    Zorat, F.5    Huang, R.6
  • 19
    • 0031464758 scopus 로고    scopus 로고
    • Overexpression of tumor necrosis factor (TNF)-Alpha and interferon (ifn)-gamma by bone marrow cells from patients with myelodysplastic syndromes
    • Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, et al. Overexpression of tumor necrosis factor (TNF)-Alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia. 1997; 11: 2049-2054
    • (1997) Leukemia , vol.11 , pp. 2049-2054
    • Kitagawa, M.1    Saito, I.2    Kuwata, T.3    Yoshida, S.4    Yamaguchi, S.5    Takahashi, M.6
  • 20
    • 0034022396 scopus 로고    scopus 로고
    • Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome
    • Deeg HJ, Beckham C, Loken MR, Bryant E, Lesnikova M, Shulman HM, et al. Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome. Leuk Lymphoma. 2000; 37: 405-414
    • (2000) Leuk Lymphoma , vol.37 , pp. 405-414
    • Deeg, H.J.1    Beckham, C.2    Loken, M.R.3    Bryant, E.4    Lesnikova, M.5    Shulman, H.M.6
  • 21
    • 0036236034 scopus 로고    scopus 로고
    • In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome
    • Flores-Figueroa E, Gutierrez-Espindola G, Montesinos JJ, Arana-Trejo RM, Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res. 2002; 26: 677-686
    • (2002) Leuk Res , vol.26 , pp. 677-686
    • Flores-Figueroa, E.1    Gutierrez-Espindola, G.2    Montesinos, J.J.3    Arana-Trejo, R.M.4    Mayani, H.5
  • 22
    • 0031656518 scopus 로고    scopus 로고
    • A role for tumour necrosis factor-Alpha, fas and fas-ligand in marrow failure associated with myelodysplastic syndrome
    • Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, et al. A role for tumour necrosis factor-Alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol. 1998; 103: 176-188
    • (1998) Br J Haematol , vol.103 , pp. 176-188
    • Gersuk, G.M.1    Beckham, C.2    Loken, M.R.3    Kiener, P.4    Anderson, J.E.5    Farrand, A.6
  • 23
    • 0037411227 scopus 로고    scopus 로고
    • Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes
    • Sawanobori M, Yamaguchi S, Hasegawa M, Inoue M, Suzuki K, Kamiyama R, et al. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leuk Res. 2003; 27: 583-591
    • (2003) Leuk Res , vol.27 , pp. 583-591
    • Sawanobori, M.1    Yamaguchi, S.2    Hasegawa, M.3    Inoue, M.4    Suzuki, K.5    Kamiyama, R.6
  • 24
    • 0036369821 scopus 로고    scopus 로고
    • Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome
    • Hsu HC, Lee YM, Tsai WH, Jiang ML, Ho CH, Ho CK, et al. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology. 2002; 63: 64-69
    • (2002) Oncology , vol.63 , pp. 64-69
    • Hsu, H.C.1    Lee, Y.M.2    Tsai, W.H.3    Jiang, M.L.4    Ho, C.H.5    Ho, C.K.6
  • 25
    • 0026588363 scopus 로고
    • In situ localization of transforming growth factor beta and s-phase cells in patients with acute myeloid leukemia and myelodysplastic syndrome
    • Qadir K, Bokhari SA, Miller MA, Siegrist C, Bismayer J, Raza A. In situ localization of transforming growth factor beta and S-phase cells in patients with acute myeloid leukemia and myelodysplastic syndrome. Anticancer Res. 1992; 12: 403-407
    • (1992) Anticancer Res , vol.12 , pp. 403-407
    • Qadir, K.1    Bokhari, S.A.2    Miller, M.A.3    Siegrist, C.4    Bismayer, J.5    Raza, A.6
  • 26
    • 0036170140 scopus 로고    scopus 로고
    • Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia
    • Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res. 2002; 11: 119-125
    • (2002) J Hematother Stem Cell Res , vol.11 , pp. 119-125
    • Brunner, B.1    Gunsilius, E.2    Schumacher, P.3    Zwierzina, H.4    Gastl, G.5    Stauder, R.6
  • 27
    • 0037085781 scopus 로고    scopus 로고
    • Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia
    • Verstovsek S, Kantarjian H, Manshouri T, Cortes J, Giles FJ, Rogers A, et al. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood. 2002; 99: 2265-2267
    • (2002) Blood , vol.99 , pp. 2265-2267
    • Verstovsek, S.1    Kantarjian, H.2    Manshouri, T.3    Cortes, J.4    Giles, F.J.5    Rogers, A.6
  • 28
    • 84866113642 scopus 로고    scopus 로고
    • The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes
    • Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, et al. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer. 2008; 113: 1605-1613
    • (2008) Cancer , vol.113 , pp. 1605-1613
    • Tsimberidou, A.M.1    Estey, E.2    Wen, S.3    Pierce, S.4    Kantarjian, H.5    Albitar, M.6
  • 29
    • 21344472917 scopus 로고    scopus 로고
    • Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
    • Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005; 104: 788-793
    • (2005) Cancer , vol.104 , pp. 788-793
    • Meyers, C.A.1    Albitar, M.2    Estey, E.3
  • 30
    • 78549250108 scopus 로고    scopus 로고
    • Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia
    • Kornblau SM, McCue D, Singh N, Chen W, Estrov Z, Coombes KR. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010; 116: 4251-4261
    • (2010) Blood , vol.116 , pp. 4251-4261
    • Kornblau, S.M.1    McCue, D.2    Singh, N.3    Chen, W.4    Estrov, Z.5    Coombes, K.R.6
  • 31
    • 79953891819 scopus 로고    scopus 로고
    • Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
    • Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, et al. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 2011; 96: 602-606
    • (2011) Haematologica , vol.96 , pp. 602-606
    • Feng, X.1    Scheinberg, P.2    Wu, C.O.3    Samsel, L.4    Nunez, O.5    Prince, C.6
  • 32
    • 84859632009 scopus 로고    scopus 로고
    • Ipss-independent prognostic value of plasma cxcl10 il-7 and il-6 levels in myelodysplastic syndromes
    • Pardanani A, Finke C, Lasho TL, Al-Kali A, Begna KH, Hanson CA, et al. IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes. Leukemia. 2012; 26: 693-699
    • (2012) Leukemia , vol.26 , pp. 693-699
    • Pardanani, A.1    Finke, C.2    Lasho, T.L.3    Al-Kali, A.4    Begna, K.H.5    Hanson, C.A.6
  • 33
    • 61849168098 scopus 로고    scopus 로고
    • Il-17-producing cd4(+) t cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
    • Kordasti SY, Afzali B, Lim Z, Ingram W, Hayden J, Barber L, et al. IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. Br J Haematol. 2009; 145: 64-72
    • (2009) Br J Haematol , vol.145 , pp. 64-72
    • Kordasti, S.Y.1    Afzali, B.2    Lim, Z.3    Ingram, W.4    Hayden, J.5    Barber, L.6
  • 34
    • 84875881003 scopus 로고    scopus 로고
    • Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification
    • Berthon C, Fontenay M, Corm S, Briche I, Allorge D, Hennart B, et al. Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification. Leuk Res. 2013; 37: 573-579
    • (2013) Leuk Res , vol.37 , pp. 573-579
    • Berthon, C.1    Fontenay, M.2    Corm, S.3    Briche, I.4    Allorge, D.5    Hennart, B.6
  • 35
    • 0028930939 scopus 로고
    • Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis
    • Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, et al. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol. 1995; 48: 143-154
    • (1995) Am J Hematol , vol.48 , pp. 143-154
    • Raza, A.1    Mundle, S.2    Iftikhar, A.3    Gregory, S.4    Marcus, B.5    Khan, Z.6
  • 36
    • 0030926080 scopus 로고    scopus 로고
    • Fas/apo-1 (cd95) expression and apoptosis in patients with myelodysplastic syndromes
    • Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, et al. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia. 1997; 11: 839-845
    • (1997) Leukemia , vol.11 , pp. 839-845
    • Bouscary, D.1    De Vos, J.2    Guesnu, M.3    Jondeau, K.4    Viguier, F.5    Melle, J.6
  • 37
    • 0032945317 scopus 로고    scopus 로고
    • Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with fab subtype and anemia, and predicts survival
    • Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C, et al. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival. Leukemia. 1999; 13: 44-53
    • (1999) Leukemia , vol.13 , pp. 44-53
    • Gupta, P.1    Niehans, G.A.2    Leroy, S.C.3    Gupta, K.4    Morrison, V.A.5    Schultz, C.6
  • 38
    • 0029016931 scopus 로고
    • Fas antigen expression on cd34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro
    • Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995; 85: 3183-3190
    • (1995) Blood , vol.85 , pp. 3183-3190
    • MacIejewski, J.1    Selleri, C.2    Anderson, S.3    Young, N.S.4
  • 39
    • 30144446015 scopus 로고    scopus 로고
    • Interferongamma-induced gene expression in cd34 cells: Identification of pathologic cytokine-specific signature profiles
    • Zeng W, Miyazato A, Chen G, Kajigaya S, Young NS, Maciejewski JP. Interferongamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood. 2006; 107: 167-175
    • (2006) Blood , vol.107 , pp. 167-175
    • Zeng, W.1    Miyazato, A.2    Chen, G.3    Kajigaya, S.4    Young, N.S.5    MacIejewski, J.P.6
  • 40
    • 85047692516 scopus 로고    scopus 로고
    • Signalling pathways of the TNF superfamily: A double-edged sword
    • Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003; 3: 745-756
    • (2003) Nat Rev Immunol , vol.3 , pp. 745-756
    • Aggarwal, B.B.1
  • 41
    • 28444479122 scopus 로고    scopus 로고
    • Nf-kappab and flip in arsenic trioxide (ato)-induced apoptosis in myelodysplastic syndromes (MDSS
    • Kerbauy DM, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). Blood. 2005; 106: 3917-3925
    • (2005) Blood , vol.106 , pp. 3917-3925
    • Kerbauy, D.M.1    Lesnikov, V.2    Abbasi, N.3    Seal, S.4    Scott, B.5    Deeg, H.J.6
  • 43
    • 0036232326 scopus 로고    scopus 로고
    • Signaling via the interferon-Alpha receptor in chronic myelogenous leukemia cells
    • Verma A, Platanias LC. Signaling via the interferon-Alpha receptor in chronic myelogenous leukemia cells. Leuk Lymphoma. 2002; 43: 703-709
    • (2002) Leuk Lymphoma , vol.43 , pp. 703-709
    • Verma, A.1    Platanias, L.C.2
  • 44
    • 55049116044 scopus 로고    scopus 로고
    • Inhibition of p38alpha mapk disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment
    • Navas T, Zhou L, Estes M, Haghnazari E, Nguyen AN, Mo Y, et al. Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment. Leuk Lymphoma. 2008; 49: 1963-1975
    • (2008) Leuk Lymphoma , vol.49 , pp. 1963-1975
    • Navas, T.1    Zhou, L.2    Estes, M.3    Haghnazari, E.4    Nguyen, A.N.5    Mo, Y.6
  • 45
    • 77950343791 scopus 로고    scopus 로고
    • Pattern recognition receptors and inflammation
    • Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010; 140: 805-820
    • (2010) Cell , vol.140 , pp. 805-820
    • Takeuchi, O.1    Akira, S.2
  • 46
    • 84877577557 scopus 로고    scopus 로고
    • Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
    • Li J, Wang X, Zhang F, Yin H. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol Ther. 2013; 138: 441-451
    • (2013) Pharmacol Ther , vol.138 , pp. 441-451
    • Li, J.1    Wang, X.2    Zhang, F.3    Yin, H.4
  • 47
    • 33744978765 scopus 로고    scopus 로고
    • Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment
    • Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity. 2006; 24: 801-812
    • (2006) Immunity , vol.24 , pp. 801-812
    • Nagai, Y.1    Garrett, K.P.2    Ohta, S.3    Bahrun, U.4    Kouro, T.5    Akira, S.6
  • 48
    • 84856709581 scopus 로고    scopus 로고
    • Deregulation of micrornas in myelodysplastic syndrome
    • Rhyasen GW, Starczynowski DT. Deregulation of microRNAs in myelodysplastic syndrome. Leukemia. 2012; 26: 13-22
    • (2012) Leukemia , vol.26 , pp. 13-22
    • Rhyasen, G.W.1    Starczynowski, D.T.2
  • 49
    • 33947255107 scopus 로고    scopus 로고
    • Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes
    • Maratheftis CI, Andreakos E, Moutsopoulos HM, Voulgarelis M. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res. 2007; 13: 1154-1160
    • (2007) Clin Cancer Res , vol.13 , pp. 1154-1160
    • Maratheftis, C.I.1    Andreakos, E.2    Moutsopoulos, H.M.3    Voulgarelis, M.4
  • 50
    • 77950629227 scopus 로고    scopus 로고
    • Expression of toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia
    • Kuninaka N, Kurata M, Yamamoto K, Suzuki S, Umeda S, Kirimura S, et al. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia. Exp Mol Pathol. 2010; 88: 293-298
    • (2010) Exp Mol Pathol , vol.88 , pp. 293-298
    • Kuninaka, N.1    Kurata, M.2    Yamamoto, K.3    Suzuki, S.4    Umeda, S.5    Kirimura, S.6
  • 52
    • 84880982508 scopus 로고    scopus 로고
    • Impaired clearance of apoptotic cells leads to hmgb1 release in the bone marrow of patients with myelodysplastic syndromes and induces tlr4-mediated cytokine production
    • Velegraki M, Papakonstanti E, Mavroudi I, Psyllaki M, Tsatsanis C, Oulas A, et al. Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production. Haematologica. 2013; 98: 1206-1215
    • (2013) Haematologica , vol.98 , pp. 1206-1215
    • Velegraki, M.1    Papakonstanti, E.2    Mavroudi, I.3    Psyllaki, M.4    Tsatsanis, C.5    Oulas, A.6
  • 53
    • 0037111773 scopus 로고    scopus 로고
    • Characterization of gene expression of cd34+ cells from normal and myelodysplastic bone marrow
    • Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood. 2002; 100: 3553-3560
    • (2002) Blood , vol.100 , pp. 3553-3560
    • Hofmann, W.K.1    De Vos, S.2    Komor, M.3    Hoelzer, D.4    Wachsman, W.5    Koeffler, H.P.6
  • 54
    • 54049105351 scopus 로고    scopus 로고
    • High-resolution whole genome tiling path array cgh analysis of cd34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
    • Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K, Brooks-Wilson A, et al. High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood. 2008; 112: 3412-3424
    • (2008) Blood , vol.112 , pp. 3412-3424
    • Starczynowski, D.T.1    Vercauteren, S.2    Telenius, A.3    Sung, S.4    Tohyama, K.5    Brooks-Wilson, A.6
  • 55
    • 38949123096 scopus 로고    scopus 로고
    • Chromosomal lesions and uniparental disomy detected by snp arrays in MDS MDS/MPD and MDS-derived AML
    • Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood. 2008; 111: 1534-1542
    • (2008) Blood , vol.111 , pp. 1534-1542
    • Gondek, L.P.1    Tiu, R.2    O'Keefe, C.L.3    Sekeres, M.A.4    Theil, K.S.5    MacIejewski, J.P.6
  • 56
    • 84881600082 scopus 로고    scopus 로고
    • Overexpression of the toll-like receptor (tlr) signaling adaptor myd88, but lack of genetic mutation, in myelodysplastic syndromes
    • Dimicoli S, Wei Y, Bueso-Ramos C, Yang H, Dinardo C, Jia Y, et al. Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes. PLoS One. 2013; 8: e71120
    • (2013) PLoS One , vol.8 , pp. e71120
    • Dimicoli, S.1    Wei, Y.2    Bueso-Ramos, C.3    Yang, H.4    Dinardo, C.5    Jia, Y.6
  • 58
    • 84887322071 scopus 로고    scopus 로고
    • Global h3k4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of jmjd3 in human myelodysplastic syndrome cd34+ cells
    • Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia. 2013; 27: 2177-2186
    • (2013) Leukemia , vol.27 , pp. 2177-2186
    • Wei, Y.1    Chen, R.2    Dimicoli, S.3    Bueso-Ramos, C.4    Neuberg, D.5    Pierce, S.6
  • 59
    • 84888876950 scopus 로고    scopus 로고
    • Differential irak signaling in hematologic malignancies
    • Rhyasen GW, Bolanos L, Starczynowski DT. Differential IRAK signaling in hematologic malignancies. Exp Hematol. 2013; 41: 1005-1007
    • (2013) Exp Hematol , vol.41 , pp. 1005-1007
    • Rhyasen, G.W.1    Bolanos, L.2    Starczynowski, D.T.3
  • 60
    • 84865183566 scopus 로고    scopus 로고
    • Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
    • Barreyro L, Will B, Bartholdy B, Zhou L, Todorova TI, Stanley RF, et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood. 2012; 120: 1290-1298
    • (2012) Blood , vol.120 , pp. 1290-1298
    • Barreyro, L.1    Will, B.2    Bartholdy, B.3    Zhou, L.4    Todorova, T.I.5    Stanley, R.F.6
  • 62
    • 84155172567 scopus 로고    scopus 로고
    • Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells
    • Boiko JR, Borghesi L. Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine. 2012; 57: 1-8
    • (2012) Cytokine , vol.57 , pp. 1-8
    • Boiko, J.R.1    Borghesi, L.2
  • 63
    • 33751315780 scopus 로고    scopus 로고
    • Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow cd34+ progenitor cells along the myeloid lineage
    • Sioud M, Floisand Y, Forfang L, Lund-Johansen F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J Mol Biol. 2006; 364: 945-954
    • (2006) J Mol Biol , vol.364 , pp. 945-954
    • Sioud, M.1    Floisand, Y.2    Forfang, L.3    Lund-Johansen, F.4
  • 64
    • 70450237721 scopus 로고    scopus 로고
    • The tlr1/2 agonist pam(3)csk(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate
    • De Luca K, Frances-Duvert V, Asensio MJ, Ihsani R, Debien E, Taillardet M, et al. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia. 2009; 23: 2063-2074
    • (2009) Leukemia , vol.23 , pp. 2063-2074
    • De Luca, K.1    Frances-Duvert, V.2    Asensio, M.J.3    Ihsani, R.4    Debien, E.5    Taillardet, M.6
  • 65
    • 84892163011 scopus 로고    scopus 로고
    • Myd88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen
    • Fiedler K, Kokai E, Bresch S, Brunner C. MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen. Am J Blood Res. 2013; 3: 124-140
    • (2013) Am J Blood Res , vol.3 , pp. 124-140
    • Fiedler, K.1    Kokai, E.2    Bresch, S.3    Brunner, C.4
  • 67
    • 70349661920 scopus 로고    scopus 로고
    • 5q- myelodysplastic syndromes: Chromosome 5q genes direct a tumorsuppression network sensing actin dynamics
    • Eisenmann KM, Dykema KJ, Matheson SF, Kent NF, DeWard AD, West RA, et al. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumorsuppression network sensing actin dynamics. Oncogene. 2009; 28: 3429-3441
    • (2009) Oncogene , vol.28 , pp. 3429-3441
    • Eisenmann, K.M.1    Dykema, K.J.2    Matheson, S.F.3    Kent, N.F.4    Deward, A.D.5    West, R.A.6
  • 68
    • 84905082105 scopus 로고    scopus 로고
    • Aberrant overexpression of cd14 on granulocytes sensitizes the innate immune response in mdia1 heterozygous del(5q) MDS
    • Keerthivasan G, Mei Y, Zhao B, Zhang L, Harris CE, Gao J, et al. Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS. Blood. 2014; 124: 780-790
    • (2014) Blood , vol.124 , pp. 780-790
    • Keerthivasan, G.1    Mei, Y.2    Zhao, B.3    Zhang, L.4    Harris, C.E.5    Gao, J.6
  • 69
    • 33645971047 scopus 로고    scopus 로고
    • Good cop, bad cop: The different faces of nf-kappab
    • Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Diff. 2006; 13: 759-772
    • (2006) Cell Death Diff , vol.13 , pp. 759-772
    • Perkins, N.D.1    Gilmore, T.D.2
  • 70
    • 0033562798 scopus 로고    scopus 로고
    • An essential role for nf-kappab in human cd34(+) bone marrow cell survival
    • Pyatt DW, Stillman WS, Yang Y, Gross S, Zheng JH, Irons RD. An essential role for NF-kappaB in human CD34(+) bone marrow cell survival. Blood. 1999; 93: 3302-3308
    • (1999) Blood , vol.93 , pp. 3302-3308
    • Pyatt, D.W.1    Stillman, W.S.2    Yang, Y.3    Gross, S.4    Zheng, J.H.5    Irons, R.D.6
  • 71
    • 31544448567 scopus 로고    scopus 로고
    • Nfkappab constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
    • Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F, et al. NFkappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006; 107: 1156-1165
    • (2006) Blood , vol.107 , pp. 1156-1165
    • Braun, T.1    Carvalho, G.2    Coquelle, A.3    Vozenin, M.C.4    Lepelley, P.5    Hirsch, F.6
  • 72
    • 34250333058 scopus 로고    scopus 로고
    • Nf-kappab inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia
    • Fabre C, Carvalho G, Tasdemir E, Braun T, Ades L, Grosjean J, et al. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene. 2007; 26: 4071-4083
    • (2007) Oncogene , vol.26 , pp. 4071-4083
    • Fabre, C.1    Carvalho, G.2    Tasdemir, E.3    Braun, T.4    Ades, L.5    Grosjean, J.6
  • 73
    • 84882436729 scopus 로고    scopus 로고
    • Deletion of the nf-kappab subunit p65/rela in the hematopoietic compartment leads to defects in hematopoietic stem cell function
    • Stein SJ, Baldwin AS. Deletion of the NF-kappaB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function. Blood. 2013; 121: 5015-5024
    • (2013) Blood , vol.121 , pp. 5015-5024
    • Stein, S.J.1    Baldwin, A.S.2
  • 74
    • 84859503920 scopus 로고    scopus 로고
    • Noncanonical nf-kappab signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions
    • Zhao C, Xiu Y, Ashton J, Xing L, Morita Y, Jordan CT, et al. Noncanonical NF-kappaB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions. Stem Cells. 2012; 30: 709-718
    • (2012) Stem Cells , vol.30 , pp. 709-718
    • Zhao, C.1    Xiu, Y.2    Ashton, J.3    Xing, L.4    Morita, Y.5    Jordan, C.T.6
  • 75
    • 33845954687 scopus 로고    scopus 로고
    • Constitutive activation of nf-kappa b is not sufficient to disturb normal steady-state hematopoiesis
    • Schepers H, Eggen BJ, Schuringa JJ, Vellenga E. Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis. Haematologica. 2006; 91: 1710-1711
    • (2006) Haematologica , vol.91 , pp. 1710-1711
    • Schepers, H.1    Eggen, B.J.2    Schuringa, J.J.3    Vellenga, E.4
  • 76
    • 20244364979 scopus 로고    scopus 로고
    • Stromamediated dysregulation of myelopoiesis in mice lacking i kappa b alpha
    • Rupec RA, Jundt F, Rebholz B, Eckelt B, Weindl G, Herzinger T, et al. Stromamediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity. 2005; 22: 479-491
    • (2005) Immunity , vol.22 , pp. 479-491
    • Rupec, R.A.1    Jundt, F.2    Rebholz, B.3    Eckelt, B.4    Weindl, G.5    Herzinger, T.6
  • 77
    • 0026672334 scopus 로고
    • Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus
    • Hawley RG, Fong AZ, Burns BF, Hawley TS. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med. 1992; 176: 1149-1163
    • (1992) J Exp Med , vol.176 , pp. 1149-1163
    • Hawley, R.G.1    Fong, A.Z.2    Burns, B.F.3    Hawley, T.S.4
  • 78
    • 22544451527 scopus 로고    scopus 로고
    • Multiple members of the TNF superfamily contribute to ifn-gamma-mediated inhibition of erythropoiesis
    • Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, Conticello C, et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol. 2005; 175: 1464-1472
    • (2005) J Immunol , vol.175 , pp. 1464-1472
    • Felli, N.1    Pedini, F.2    Zeuner, A.3    Petrucci, E.4    Testa, U.5    Conticello, C.6
  • 79
    • 11844299080 scopus 로고    scopus 로고
    • Ifn-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells
    • Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, et al. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol. 2005; 174: 752-757
    • (2005) J Immunol , vol.174 , pp. 752-757
    • Yang, L.1    Dybedal, I.2    Bryder, D.3    Nilsson, L.4    Sitnicka, E.5    Sasaki, Y.6
  • 80
    • 1642513702 scopus 로고    scopus 로고
    • Stimulation of human toll-like receptor (tlr) 2 and tlr6 with membrane lipoproteins of mycoplasma fermentans induces apoptotic cell death after nf-kappa b activation
    • Into T, Kiura K, Yasuda M, Kataoka H, Inoue N, Hasebe A, et al. Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol. 2004; 6: 187-199
    • (2004) Cell Microbiol , vol.6 , pp. 187-199
    • Into, T.1    Kiura, K.2    Yasuda, M.3    Kataoka, H.4    Inoue, N.5    Hasebe, A.6
  • 83
    • 18544371666 scopus 로고    scopus 로고
    • Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
    • Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005; 105: 4120-4126
    • (2005) Blood , vol.105 , pp. 4120-4126
    • Jiang, X.X.1    Zhang, Y.2    Liu, B.3    Zhang, S.X.4    Wu, Y.5    Yu, X.D.6
  • 85
    • 77954928083 scopus 로고    scopus 로고
    • Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes
    • Klaus M, Stavroulaki E, Kastrinaki MC, Fragioudaki P, Giannikou K, Psyllaki M, et al. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev. 2010; 19: 1043-1054
    • (2010) Stem Cells Dev , vol.19 , pp. 1043-1054
    • Klaus, M.1    Stavroulaki, E.2    Kastrinaki, M.C.3    Fragioudaki, P.4    Giannikou, K.5    Psyllaki, M.6
  • 86
    • 84874639295 scopus 로고    scopus 로고
    • The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes
    • Wang Z, Tang X, Xu W, Cao Z, Sun L, Li W, et al. The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes. PLoS One. 2013; 8: e57470
    • (2013) PLoS One , vol.8 , pp. e57470
    • Wang, Z.1    Tang, X.2    Xu, W.3    Cao, Z.4    Sun, L.5    Li, W.6
  • 87
    • 84902200836 scopus 로고    scopus 로고
    • Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit
    • Medyouf H, Mossner M, Jann JC, Nolte F, Raffel S, Herrmann C, et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 2014; 14: 824-837
    • (2014) Cell Stem Cell , vol.14 , pp. 824-837
    • Medyouf, H.1    Mossner, M.2    Jann, J.C.3    Nolte, F.4    Raffel, S.5    Herrmann, C.6
  • 89
  • 90
    • 61349100687 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells as regulators of the immune system
    • Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009; 9: 162-174
    • (2009) Nat Rev Immunol , vol.9 , pp. 162-174
    • Gabrilovich, D.I.1    Nagaraj, S.2
  • 92
    • 34948900275 scopus 로고    scopus 로고
    • Mrp8 and mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock
    • Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007; 13: 1042-1049
    • (2007) Nat Med , vol.13 , pp. 1042-1049
    • Vogl, T.1    Tenbrock, K.2    Ludwig, S.3    Leukert, N.4    Ehrhardt, C.5    Van Zoelen, M.A.6
  • 93
    • 79951812916 scopus 로고    scopus 로고
    • Telomere dysfunction induces metabolic and mitochondrial compromise
    • Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011; 470: 359-365
    • (2011) Nature , vol.470 , pp. 359-365
    • Sahin, E.1    Colla, S.2    Liesa, M.3    Moslehi, J.4    Muller, F.L.5    Guo, M.6
  • 94
    • 77956920766 scopus 로고    scopus 로고
    • Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells
    • Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010; 185: 2273-2284
    • (2010) J Immunol , vol.185 , pp. 2273-2284
    • Lechner, M.G.1    Liebertz, D.J.2    Epstein, A.L.3
  • 96
    • 67650065350 scopus 로고    scopus 로고
    • Patients with myelodysplastic syndromes display several t-cell expansions, which are mostly polyclonal in the cd4(+) subset and oligoclonal in the cd8(+) subset
    • Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, et al. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Exp Hematol. 2009; 37: 947-955
    • (2009) Exp Hematol , vol.37 , pp. 947-955
    • Fozza, C.1    Contini, S.2    Galleu, A.3    Simula, M.P.4    Virdis, P.5    Bonfigli, S.6
  • 97
    • 62549141807 scopus 로고    scopus 로고
    • Kinetics, function and bone marrow trafficking of cd4+cd25+foxp3+ regulatory t cells in myelodysplastic syndromes (MDS
    • Kotsianidis I, Bouchliou I, Nakou E, Spanoudakis E, Margaritis D, Christophoridou AV, et al. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia. 2009; 23: 510-518
    • (2009) Leukemia , vol.23 , pp. 510-518
    • Kotsianidis, I.1    Bouchliou, I.2    Nakou, E.3    Spanoudakis, E.4    Margaritis, D.5    Christophoridou, A.V.6
  • 99
    • 79953100658 scopus 로고    scopus 로고
    • T-cell immune responses to wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy
    • Sloand EM, Melenhorst JJ, Tucker ZC, Pfannes L, Brenchley JM, Yong A, et al. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy. Blood. 2011; 117: 2691-2699
    • (2011) Blood , vol.117 , pp. 2691-2699
    • Sloand, E.M.1    Melenhorst, J.J.2    Tucker, Z.C.3    Pfannes, L.4    Brenchley, J.M.5    Yong, A.6
  • 100
    • 18744412931 scopus 로고    scopus 로고
    • Autologous lymphocytes inhibit hemopoiesis in long-Term culture in patients with myelodysplastic syndrome
    • Baumann I, Scheid C, Koref MS, Swindell R, Stern P, Testa NG. Autologous lymphocytes inhibit hemopoiesis in long-Term culture in patients with myelodysplastic syndrome. Exp Hematol. 2002; 30: 1405-1411
    • (2002) Exp Hematol , vol.30 , pp. 1405-1411
    • Baumann, I.1    Scheid, C.2    Koref, M.S.3    Swindell, R.4    Stern, P.5    Testa, N.G.6
  • 101
    • 84876704647 scopus 로고    scopus 로고
    • Interleukin-17 enhances the production of interferon-gamma and tumour necrosis factor-Alpha by bone marrow t lymphocytes from patients with lower risk myelodysplastic syndromes
    • Zhang Z, Li X, Guo J, Xu F, He Q, Zhao Y, et al. Interleukin-17 enhances the production of interferon-gamma and tumour necrosis factor-Alpha by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes. Eur J Haematol. 2013; 90: 375-384
    • (2013) Eur J Haematol , vol.90 , pp. 375-384
    • Zhang, Z.1    Li, X.2    Guo, J.3    Xu, F.4    He, Q.5    Zhao, Y.6
  • 102
    • 77954536742 scopus 로고    scopus 로고
    • In vitro deprivation of cd8(+)cd57(+)t cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome
    • Zheng Z, Qianqiao Z, Qi H, Feng X, Chunkang C, Xiao L. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Exp Hematol. 2010; 38: 677-684
    • (2010) Exp Hematol , vol.38 , pp. 677-684
    • Zheng, Z.1    Qianqiao, Z.2    Qi, H.3    Feng, X.4    Chunkang, C.5    Xiao, L.6
  • 103
    • 34547957665 scopus 로고    scopus 로고
    • Cd4 +cd25high foxp3+ regulatory t cells in myelodysplastic syndrome (MDS
    • Kordasti SY, Ingram W, Hayden J, Darling D, Barber L, Afzali B, et al. CD4 +CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood. 2007; 110: 847-850
    • (2007) Blood , vol.110 , pp. 847-850
    • Kordasti, S.Y.1    Ingram, W.2    Hayden, J.3    Darling, D.4    Barber, L.5    Afzali, B.6
  • 104
    • 34249740754 scopus 로고    scopus 로고
    • ReduceDNAtural killer (nk) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating nk receptors
    • Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, et al. ReduceDNAtural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood. 2007; 109: 4816-4824
    • (2007) Blood , vol.109 , pp. 4816-4824
    • Epling-Burnette, P.K.1    Bai, F.2    Painter, J.S.3    Rollison, D.E.4    Salih, H.R.5    Krusch, M.6
  • 105
    • 84866152555 scopus 로고    scopus 로고
    • Expansion of effector memory regulatory t cells represents a novel prognostic factor in lower risk myelodysplastic syndrome
    • Mailloux AW, Sugimori C, Komrokji RS, Yang L, Maciejewski JP, Sekeres MA, et al. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol. 2012; 189: 3198-3208
    • (2012) J Immunol , vol.189 , pp. 3198-3208
    • Mailloux, A.W.1    Sugimori, C.2    Komrokji, R.S.3    Yang, L.4    MacIejewski, J.P.5    Sekeres, M.A.6
  • 106
    • 33644538600 scopus 로고    scopus 로고
    • Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes
    • Kiladjian JJ, Bourgeois E, Lobe I, Braun T, Visentin G, Bourhis JH, et al. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia. 2006; 20: 463-470
    • (2006) Leukemia , vol.20 , pp. 463-470
    • Kiladjian, J.J.1    Bourgeois, E.2    Lobe, I.3    Braun, T.4    Visentin, G.5    Bourhis, J.H.6
  • 107
    • 0037376257 scopus 로고    scopus 로고
    • Determination of t-cell receptors of clonal cd8-positive t-cells in myelodysplastic syndrome with erythroid hypoplasia
    • Matsutani T, Yoshioka T, Tsuruta Y, Shimamoto T, Ohyashiki JH, Suzuki R, et al. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia. Leuk Res. 2003; 27: 305-312
    • (2003) Leuk Res , vol.27 , pp. 305-312
    • Matsutani, T.1    Yoshioka, T.2    Tsuruta, Y.3    Shimamoto, T.4    Ohyashiki, J.H.5    Suzuki, R.6
  • 108
    • 0034765667 scopus 로고    scopus 로고
    • Increased cytotoxic t cells with effector phenotype in aplastic anemia and myelodysplasia
    • Kook H, Zeng W, Guibin C, Kirby M, Young NS, Maciejewski JP. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp Hematol. 2001; 29: 1270-1277
    • (2001) Exp Hematol , vol.29 , pp. 1270-1277
    • Kook, H.1    Zeng, W.2    Guibin, C.3    Kirby, M.4    Young, N.S.5    MacIejewski, J.P.6
  • 109
    • 84902075577 scopus 로고    scopus 로고
    • Expression of pd-l1, pd-l2, pd-1 and ctla4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
    • Yang H, Bueso-Ramos C, DiNardo C, Estecio MR, Davanlou M, Geng QR, et al. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents. Leukemia. 2014; 28: 1280-1288
    • (2014) Leukemia , vol.28 , pp. 1280-1288
    • Yang, H.1    Bueso-Ramos, C.2    Dinardo, C.3    Estecio, M.R.4    Davanlou, M.5    Geng, Q.R.6
  • 110
    • 27644572272 scopus 로고    scopus 로고
    • Evidence for reduced b-cell progenitors in early (low-risk) myelodysplastic syndrome
    • Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, Seidl T, et al. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood. 2005; 106: 2982-2991
    • (2005) Blood , vol.106 , pp. 2982-2991
    • Sternberg, A.1    Killick, S.2    Littlewood, T.3    Hatton, C.4    Peniket, A.5    Seidl, T.6
  • 111
    • 40849127239 scopus 로고    scopus 로고
    • Activation of cytotoxic t-cell receptor gammadelta t lymphocytes in response to specific stimulation in myelodysplastic syndromes
    • Kiladjian JJ, Visentin G, Viey E, Chevret S, Eclache V, Stirnemann J, et al. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes. Haematologica. 2008; 93: 381-389
    • (2008) Haematologica , vol.93 , pp. 381-389
    • Kiladjian, J.J.1    Visentin, G.2    Viey, E.3    Chevret, S.4    Eclache, V.5    Stirnemann, J.6
  • 113
    • 84864495501 scopus 로고    scopus 로고
    • Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of traf6 and repression of psma1
    • Fang J, Rhyasen G, Bolanos L, Rasch C, Varney M, Wunderlich M, et al. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1. Blood. 2012; 120: 858-867
    • (2012) Blood , vol.120 , pp. 858-867
    • Fang, J.1    Rhyasen, G.2    Bolanos, L.3    Rasch, C.4    Varney, M.5    Wunderlich, M.6
  • 114
    • 33845474265 scopus 로고    scopus 로고
    • Inhibition of overactivated p38 mapk can restore hematopoiesis in myelodysplastic syndrome progenitors
    • Navas TA, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, et al. Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood. 2006; 108: 4170-4177
    • (2006) Blood , vol.108 , pp. 4170-4177
    • Navas, T.A.1    Mohindru, M.2    Estes, M.3    Ma, J.Y.4    Sokol, L.5    Pahanish, P.6
  • 115
    • 84937024000 scopus 로고    scopus 로고
    • Inhibition of cxcr2 as a therapeutic strategy in AML and MDS [ash 2013 abstract 484
    • Schinke C, Giricz O, Gordon SAK, Barreyro L, Bhagat TD, Pellagatti A, et al. Inhibition of CXCR2 as a therapeutic strategy in AML and MDS [ASH 2013 Abstract 484]. Blood. 2013; 122: 484
    • (2013) Blood , vol.122 , pp. 484
    • Schinke, C.1    Giricz, O.2    Gordon, S.A.K.3    Barreyro, L.4    Bhagat, T.D.5    Pellagatti, A.6
  • 116
    • 85015970319 scopus 로고    scopus 로고
    • Phase i dose-escalation/expansion study of arry-614 in patients with ipss low/int-1 risk myelodysplastic syndromes [ash 2013 abstract 484
    • Garcia-Manero G, Sekeres MA, List AF, Khoury HJ, Advani A, Jabbour E, et al. Phase I dose-escalation/expansion study of ARRY-614 in patients with IPSS Low/Int-1 Risk Myelodysplastic Syndromes [ASH 2013 Abstract 484]. Blood. 2013; 122: 387
    • (2013) Blood , vol.122 , pp. 387
    • Garcia-Manero, G.1    Sekeres, M.A.2    List, A.F.3    Khoury, H.J.4    Advani, A.5    Jabbour, E.6
  • 117
    • 84886725015 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, dose-escalating phase i, healthy subjects study of intravenous opn-305, a humanized anti-Tlr2 antibody
    • Reilly M, Miller RM, Thomson MH, Patris V, Ryle P, McLoughlin L, et al. Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody. Clin Pharmacol Ther. 2013; 94: 593-600
    • (2013) Clin Pharmacol Ther , vol.94 , pp. 593-600
    • Reilly, M.1    Miller, R.M.2    Thomson, M.H.3    Patris, V.4    Ryle, P.5    McLoughlin, L.6
  • 118
    • 79551518231 scopus 로고    scopus 로고
    • Reduced smad7 leads to overactivation of tgf-beta signaling in MDS that can be reversed by a specific inhibitor of tgf-beta receptor i kinase
    • Zhou L, McMahon C, Bhagat T, Alencar C, Yu Y, Fazzari M, et al. Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. Cancer Res. 2011; 71: 955-963
    • (2011) Cancer Res , vol.71 , pp. 955-963
    • Zhou, L.1    McMahon, C.2    Bhagat, T.3    Alencar, C.4    Yu, Y.5    Fazzari, M.6
  • 119
    • 77951718214 scopus 로고    scopus 로고
    • Selective inhibition of ido1 effectively regulates mediators of antitumor immunity
    • Liu X, Shin N, Koblish HK, Yang G, Wang Q, Wang K, et al. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood. 2010; 115: 3520-3530
    • (2010) Blood , vol.115 , pp. 3520-3530
    • Liu, X.1    Shin, N.2    Koblish, H.K.3    Yang, G.4    Wang, Q.5    Wang, K.6
  • 120
    • 84898606191 scopus 로고    scopus 로고
    • Overexpression of mir-125a in myelodysplastic syndrome cd34+ cells modulates nf-kappab activation and enhances erythroid differentiation arrest
    • Ganan-Gomez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, et al. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-kappaB activation and enhances erythroid differentiation arrest. PLoS One. 2014; 9: e93404
    • (2014) PLoS One , vol.9 , pp. e93404
    • Ganan-Gomez, I.1    Wei, Y.2    Yang, H.3    Pierce, S.4    Bueso-Ramos, C.5    Calin, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.